Journal of Applied Physiology, Vol 76, Issue 1 345-355, Copyright © 1994 by American Physiological Society

ARTICLES

Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS

I. Rovira, T. Y. Chen, M. Winkler, N. Kawai, K. D. Bloch and W. M. Zapol
Department of Anaesthesia, Harvard Medical School, Massachusetts General Hospital, Boston 02114.

Inhaling low concentrations of nitric oxide (NO) gas causes selective pulmonary vasodilation of ventilated lung regions. NO activates soluble guanylate cyclase, increasing guanosine 3',5'-cyclic monophosphate (cGMP). Inhibition of NO synthesis enhances hypoxic pulmonary vasoconstriction. Therefore we examined independent and combined effects of NO inhalation and infusion of NG-nitro-L-arginine methyl ester (L-NAME), an NO synthesis inhibitor, on pulmonary vascular pressure-flow relationships, gas exchange, and plasma cGMP levels in anesthetized and mechanically ventilated sheep with acute lung injury induced by bilateral lavage. After lavage, inhaling 60 ppm by volume of NO decreased pulmonary arterial pressure (PAP) and resistance without any systemic hemodynamic effects, increased arterial PO2, and decreased venous admixture (Qva/QT; all P < 0.05) without altering cardiac output (QT), mixed venous PO2, or O2 uptake, major determinants of intrapulmonary shunt. During NO inhalation, PAP-left atrial pressure gradient (PAP-LAP) and Qva/QT were reduced (both P < 0.05) independently of QT, which was varied mechanically. L-NAME infusion produced systemic and pulmonary vasoconstriction and increased PAP-LAP gradient across the entire range of QT, whereas Qva/QT, was not changed. NO inhalation after L-NAME infusion produced pulmonary vasodilation and decreased Qva/QT to the same degree as NO inhalation alone. Five to 10 min after inhalation of 60 ppm NO, before and after L-NAME infusion, arterial plasma cGMP levels were increased by 80% (both P < 0.05). With NO breathing after L-NAME, we measured a consistent transpulmonary cGMP arteriovenous gradient [31 +/- 8 and 33 +/- 7 (SE) pmol/ml at 5 and 10 min, respectively; both P < 0.05]. NO inhalation before or after L-NAME administration in this acute lung injury model reduced Qva/QT, most likely by increasing cGMP concentration in ventilated lung regions and causing selective pulmonary vasodilation.

This article has been cited by other articles:

				M. Filaire, E. Fadel, B. Decante, F. Seccatore, G.-M. Mazmanian, and P. Herve Inhaled nitric oxide does not prevent postpneumonectomy pulmonary edema in pigs J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 770 - 774. [Abstract] [Full Text] [PDF]

				P. Fesler, A. Pagnamenta, B. Rondelet, F. Kerbaul, and R. Naeije Effects of sildenafil on hypoxic pulmonary vascular function in dogs J Appl Physiol, October 1, 2006; 101(4): 1085 - 1090. [Abstract] [Full Text] [PDF]

				O. V. Evgenov, F. Ichinose, N. V. Evgenov, M. J. Gnoth, G. E. Falkowski, Y. Chang, K. D. Bloch, and W. M. Zapol Soluble Guanylate Cyclase Activator Reverses Acute Pulmonary Hypertension and Augments the Pulmonary Vasodilator Response to Inhaled Nitric Oxide in Awake Lambs Circulation, October 12, 2004; 110(15): 2253 - 2259. [Abstract] [Full Text] [PDF]

				R. W. Taylor, J. L. Zimmerman, R. P. Dellinger, R. C. Straube, G. J. Criner, K. Davis Jr, K. M. Kelly, T. C. Smith, and R. J. Small Low-Dose Inhaled Nitric Oxide in Patients With Acute Lung Injury: A Randomized Controlled Trial JAMA, April 7, 2004; 291(13): 1603 - 1609. [Abstract] [Full Text] [PDF]

				M. Fujita, R. J. Mason, C. Cool, J. M. Shannon, N. Hara, and K. A. Fagan Pulmonary hypertension in TNF-alpha -overexpressing mice is associated with decreased VEGF gene expression J Appl Physiol, December 1, 2002; 93(6): 2162 - 2170. [Abstract] [Full Text] [PDF]

				L. J. BJERTNAES, T. KOIZUMI, and J. H. NEWMAN Inhaled Nitric Oxide Reduces Lung Fluid Filtration after Endotoxin in Awake Sheep Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1416 - 1423. [Abstract] [Full Text] [PDF]

				N. KERMARREC, P. ZUNIC, S. BELOUCIF, J. BENESSIANO, L. DROUET, and D. PAYEN Impact of Inhaled Nitric Oxide on Platelet Aggregation and Fibrinolysis in Rats with Endotoxic Lung Injury . Role of Cyclic Guanosine 5'-monophosphate Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 833 - 839. [Abstract] [Full Text] [PDF]

				A. Gries, C. Bode, K. Peter, A. Herr, H. Bohrer, J. Motsch, and E. Martin Inhaled Nitric Oxide Inhibits Human Platelet Aggregation, P-Selectin Expression, and Fibrinogen Binding In Vitro and In Vivo Circulation, April 21, 1998; 97(15): 1481 - 1487. [Abstract] [Full Text] [PDF]

				B. E. Marshall, L. Chen, H. F. Frasch, C. W. Hanson, and C. Marshall Improved oxygenation with prostaglandin F2alpha with and without inhaled nitric oxide in dogs J Appl Physiol, April 1, 1998; 84(4): 1350 - 1358. [Abstract] [Full Text] [PDF]

				S. C. Body and S. K. Shernan The Utility of Nitric Oxide in the Postoperative Period Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 4 - 30. [Abstract] [PDF]

				Z. M. N. Quezado, C. Natanson, W. Karzai, R. L. Danner, C. A. Koev, Y. Fitz, D. P. Dolan, S. Richmond, S. M. Banks, L. Wilson, et al. Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsis J Appl Physiol, January 1, 1998; 84(1): 107 - 115. [Abstract] [Full Text] [PDF]

				C. MLOT, F. VERMEULEN, M. MAGGIORINI, E. GILBERT, and R. NAEIJE Site of Pulmonary Vasodilation by Inhaled Nitric Oxide in Microembolic Lung Injury Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 75 - 85. [Abstract] [Full Text]

				S. R. HOPKINS, E. C. JOHNSON, R. S. RICHARDSON, H. WAGNER, M. DE ROSA, and P. D. WAGNER Effects of Inhaled Nitric Oxide on Gas Exchange in Lungs with Shunt or Poorly Ventilated Areas Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 484 - 491. [Abstract] [Full Text]